Location History:
- Maplewood, MN (US) (2008 - 2009)
- Woodbury, MN (US) (2017 - 2019)
Company Filing History:
Years Active: 2008-2019
Title: The Innovative Contributions of Keith B. Gorden
Introduction
Keith B. Gorden is a notable inventor based in Woodbury, Minnesota, with a remarkable portfolio of nine patents. His work primarily focuses on compositions that enhance immune responses and improve therapeutic outcomes in various medical applications.
Latest Patents
Among his latest patents, Gorden has developed compositions that include beta-glucans and methods of use. One significant invention relates to soluble beta-glucan compositions that serve as adjuvants in pharmaceutical formulations. This invention describes a combination of soluble beta-glucan and a TLR agonist, which together effectively boost a subject's immune response to an antigen. Another important patent involves methods and compositions that influence the tumor microenvironment. This disclosure highlights the synergistic effects of soluble beta-glucan and immune suppression-relieving agents, promoting an immunostimulatory environment that enhances the efficacy of anti-angiogenics and checkpoint inhibitors.
Career Highlights
Gorden has made significant contributions to the field of immunology and pharmaceutical sciences. His innovative approaches have been recognized in various research and development settings. He has worked with prominent companies such as Biothera Inc. and 3M Innovative Properties Company, where he has applied his expertise to advance medical technologies.
Collaborations
Throughout his career, Gorden has collaborated with esteemed colleagues, including Nandita Bose and Xiaohong Qiu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the field of immunology.
Conclusion
Keith B. Gorden's contributions to the field of immunology through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the development of effective therapeutic strategies that enhance immune responses and improve patient outcomes.